Larson Financial Group’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Larson Financial Group’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-833	Closed	-$608	–	3898
2026 Q1	$608	Buy	833 +1	+0.1%	+$5	﹤0.01%	3277
2025 Q4	$4.64K	Sell	832 -918	-52%	-$10.2K	﹤0.01%	2489
2025 Q3	$12.9K	Buy	+1,750	New	+$14.9K	﹤0.01%	1890

Other funds holding RVPH

ECM

EMC Capital Management Houston, Texas $253M AUM

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PUI

Purpose Unlimited Inc Toronto $2.62B AUM

MGI

Miller Global Investments Dallas, Texas $121M AUM

MWM

Mosley Wealth Management Anaheim, California $314M AUM

Larson Financial Group's RVPH Position: Q2 2026 in Review

Larson Financial Group sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 833 shares — an estimated $608 sold.

Larson Financial Group first reported a position in RVPH in Q3 2025 and held it in 3 quarters. The position peaked at $12.9K in Q3 2025. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

Larson Financial Group reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
Larson Financial Group sold 833 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $608.
Larson Financial Group first reported a position in REVIVA PHARMA HLDGS INC in Q3 2025 and held it in 3 quarters.
Larson Financial Group's REVIVA PHARMA HLDGS INC position peaked at $12.9K in Q3 2025.
5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.